Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach

摘要

BackgroundThis study's aim was to develop a first quantification of the frequency and costs of adverse drug events (ADEs) originating in ambulatory medical practice in Germany.